Celltrion
068270.KS
#737
Rank
HK$210.48 B
Marketcap
HK$978.11
Share price
0.45%
Change (1 day)
-9.14%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Market capitalization of Celltrion (068270.KS)

Market cap: HK$210.48 Billion

As of January 2025 Celltrion has a market cap of HK$210.48 Billion. This makes Celltrion the world's 737th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celltrion from 2007 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$210.48 B2.74%
2024HK$204.87 B-21.65%
2023HK$261.48 B84.59%
2022HK$141.65 B-21.65%
2021HK$180.80 B-48.28%
2020HK$349.55 B125.42%
2019HK$155.07 B-20.27%
2018HK$194.48 B-3.29%
2017HK$201.10 B138.56%
2016HK$84.29 B34.57%
2015HK$62.64 B123%
2014HK$28.09 B1.56%
2013HK$27.66 B-17.88%
2012HK$33.68 B18.76%
2011HK$28.36 B5.71%
2010HK$26.82 B162.37%
2009HK$10.22 B64.06%
2008HK$6.23 B4178.81%
2007HK$0.14 B

End of Day market cap according to different sources

On Jan 21st, 2025 the market cap of Celltrion was reported to be:

HK$210.13 Billion
by Yahoo Finance info icon info icon
HK$210.13 Billion
by CompaniesMarketCap info icon info icon